Cancer Risk Blood Test for Men – Comprehensive (19 Biomarkers)

This comprehensive panel is designed for men who want a broad, blood-based overview of tumour markers across multiple organ systems. It brings together 17 markers that are commonly used to support clinical assessment of gastrointestinal, gynaecological, breast, lung, and other cancers. It is not a diagnostic test for cancer, but it can provide useful information that your doctor can interpret alongside your history, symptoms, and other investigations.

General and gastrointestinal tumour markers
- Carcinoembryonic antigen (CEA): often associated with colorectal and other gastrointestinal cancers.
- Alpha-fetoprotein (AFP): primarily linked to liver and germ cell tumours.
- Carbohydrate antigen 19-9 (CA 19-9): commonly used in pancreatic and biliary tract assessment.
- CA 72-4: associated with gastric and ovarian cancers.
- CA 242: a marker used in gastrointestinal, particularly pancreatic, assessment.

Gynaecological and breast tumour markers
- Carbohydrate antigen 125 (CA 125): primarily associated with ovarian cancer.
- Carbohydrate antigen 15-3 (CA 15-3): commonly used in breast cancer assessment.

Additional tumour markers
- CYFRA 21-1: often associated with lung cancer, particularly non-small cell lung cancer.
- NSE (neuron-specific enolase): associated with neuroendocrine tumours and small cell lung cancer.
- ProGRP: a marker for small cell lung cancer and neuroendocrine tumours.
- hCG + β (human chorionic gonadotrophin and beta subunit): associated with germ cell tumours and some other cancers.
- Ferritin: an iron storage protein that can be elevated in certain cancers and liver conditions.
- β2-Microglobulin: associated with haematological cancers such as myeloma and lymphoma.
- SCC (squamous cell carcinoma antigen): associated with squamous cell carcinomas, including lung, head and neck, and cervical cancers.
- H. pylori antibody: indicates past or present infection with Helicobacter pylori, a risk factor for gastric cancer.
- Pepsinogen I and Pepsinogen II (and the PG I/II ratio): markers of gastric mucosal health and potential gastric cancer risk.

Why it matters
Tumour markers can offer useful clues about what may be happening in the body, but they are not definitive on their own. This panel gives you and your doctor a broad set of results to consider together with your clinical picture. It can help guide further discussion, targeted investigations, or reassurance, and it supports a proactive approach to men's health.